Josep Torrent-Farnell
Personal information
•
First name / Surname: Josep Torrent-Farnell
Employment and Work Experience
Period
Position
1992 to present
Full Professor of Clinical Pharmacology and Therapeutics at the Autonomous
University of Barcelona (Universitat Autònoma de Barcelona -UAB) and Clinical Heath
of Clinical Pharmacology Department at Hospital de la Santa Creu i Sant Pau. Barcelona
Director General of the Fundació Doctor Robert-UAB, Advanced Centre of Services
and Training for Health and Life Sciences, created by the Autonomous University of
Barcelona in 1998. Barcelona
In 1998: Responsible for the creation of the Spanish Medicines Agency. Madrid
And from 1999 to 2000: first elected Executive Director of the Spanish Medicines
Agency. Madrid
From 1994 to 1998, Head of the New Chemical Substances Sector (EMA). London
Technical Counsellor and Head of Clinical Evaluation and Pharmacology Department
at the Spanish Ministry of Health. Madrid
CPMP Spanish alternate member. Member of the Efficacy Working Party (EWP).
Brussels. DG Enterprise. European Commission
2000 to present
1998-2000
1994-1998
1990-1994
1990-1994
Orphan Medicines Experience
Period
Position
2000 to present
2000- 2006: Chairperson of the Committee for Orphan Medicinal Products of the
European Medicines Agency (EMA). Re-elected, as a Chairperson, in May 2003. Since
June 2006, member of the COMP, nominated by Spain. London
Member of the Scientific Advice Working Party (SAWP) -European Medicines Agency,
nominated by COMP. London
Member of the Advisory Board on Rare Diseases. Catalan Health Department. Barcelona
Chair, Catalan Government Commission for Access to Orphan and Advanced Therapies.
Catalan Health Department. Barcelona
2010 to present
2009 to present
2010 to present
2012
Member of the Therapies Scientific Committee of the International Rare Diseases Research
Consortium (IRDiRC)
Candidature pour le “Conseil scientifique de l’Agence nationale de sécurité du médicament et des produits de santé
(ANSM)»
Josep Torrent-Farnell
2010 to present
2007-2009
2010 to present
2009
2006-2010
2007
2009
2006-2008
2009-2011
19th June 2012
Invited expert at the International Rare Diseases Research Consortium (IRDiRC):
• Workshop EU/US Fostering trans-Atlantic cooperation on rare diseases, 27-28
October 2010 Reykjavik - Iceland
• Fostering international collaboration on rare diseases research: launch of the
IRDiRC - April 6-8, 2011 - Bethesda, MD, USA
• Fostering International Cooperation on Research into Rare Diseases -Third
Meeting of the International Rare Diseases Research Consortium -IRDiRC Montreal 8-9 October 2011
Member of the Rare Diseases Task Force (DG SANCO. European Commission).
Luxembourg
Chair, External Advisory Scientific Committee (EASC) of CIBERER Centre for
Biomedical Network Research on Rare Diseases –Spain (Centro de Investigación
Biomédica en Red de Enfermedades Raras ). Instituto de Salud Carlos III. Ministry of
Health. Madrid
Expert of the Spanish Strategic Plan for Rare Diseases (Estrategia en Enfermedades
Raras del Sistema Nacional de Salud) Spanish Ministry of Health. Madrid.
Member of the Selection Committee for Non-Commercial Clinical Research (Comité de
Selección de Investigación Clínica Independiente). Spanish Ministry of Health. Madrid
Member of the Working Group for Reference Centres and Expert Units for Rare
Diseases. Spanish Ministry of Health. Madrid
Member of the Advisory Board LA MARATÓ TV3 2009 on Rare Diseases. Barcelona
Co-chair, Programme Committee, European Conference on Rare Diseases. Lisbon
2007. RAPSODY Steering Committee (The Rare Disease Patient Solidarity Project).
EURORDIS (European Organisation for Rare Diseases) and DG SANCO. European
Commission
Co-chair, Programme Committee, European Conference on Rare Diseases. Krakow
2010. POLKA Steering Committee (Patients’ Consensus on Preferred Policy Scenarii
for Rare Diseases) EURORDIS and DG SANCO. European Commission.
Other relevant experience in drug development and medicines evaluation
Period
Position
2007 to present
Member, Advisory Board for assessing effectiveness and pricing of innovative therapies,
at the General Directorate of Pharmacy and Medical Devices. Spanish Ministry of Health.
Madrid
Member, Management Board of the Spanish Agency of Medicines and Health Products,
Spanish Ministry of Health. Madrid.
Member, Health Assessor Council. Department of Health. Catalan Government.
Barcelona. Barcelona
Member, Pharmacoeconomic Evaluation Committee for Innovative Medicines.
Department of Health. Catalan Government. Barcelona.
Member of the EPPOSI Organising Committee Meeting (European Platform for
Patients’ Organisations, Science and Industry)
Member of the PERF (Pan European Regulatory Forum) for the preparatory access to
the European Union of central and eastern European countries. DG Enterprise
European Regulatory Expert. Efficacy Track. International Conference on
2005-2011
2004 - 2010
2004 to present
2001-2005
1998-2002
1990-1997
Candidature pour le “Conseil scientifique de l’Agence nationale de sécurité du médicament et des produits de santé
(ANSM)»
2
Josep Torrent-Farnell
1977-1990
19th June 2012
Harmonisation (ICH). Brussels 1990. Florida 1993. Tokyo 1995.
Coordinator of the Emergencies Services in Health Care in Badalona. Catalan Institute
3
of Health and internist at the Internal Medicine Department of the Hospital Sant Pau, in
Barcelona.
Education
Qualified Pharmacist and Degree in Medicine and Surgery from the University of Barcelona, 1977. PhD in
Medicine of the Autonomous University of Barcelona. Master in Pharmacology and Toxicology, University
of Barcelona, 1980. Postgraduate Diploma in Public Health, Medical Science Academy, 1981. Physician
Specialist in Internal Medicine and Clinical Pharmacology, Autonomous University of Barcelona, 1992.
Postgraduate Diplome in European Union Institutions, School of Diplomatics. Foreign Affairs Ministry,
Madrid, 1993.
Publications and congress
Active participation in more of 235 medical conferences and 64 articles published in medical journals.
Candidature pour le “Conseil scientifique de l’Agence nationale de sécurité du médicament et des produits de santé
(ANSM)»